Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats

Addiction Biology
Hai-Ying ZhangZheng-Xiong Xi

Abstract

We have recently reported the expression of functional cannabinoid CB2 receptors (CB2 Rs) in midbrain dopamine (DA) neurons in mice. However, little is known whether CB2 Rs are similarly expressed in rat brain because significant species differences in CB2 R structures and expression are found. In situ hybridization and immunohistochemical assays detected CB2 gene and receptors in DA neurons of the ventral tegmental area (VTA), which was up-regulated in cocaine self-administration rats. Electrophysiological studies demonstrated that activation of CB2 Rs by JWH133 inhibited VTA DA neuronal firing in single dissociated neurons. Systemic administration of JWH133 failed to alter, while local administration of JWH133 into the nucleus accumbens inhibited cocaine-enhanced extracellular DA and i.v. cocaine self-administration. This effect was blocked by AM630, a selective CB2 R antagonist. These data suggest that CB2 Rs are expressed in VTA DA neurons and functionally modulate DA neuronal activities and cocaine self-administration behavior in rats.

References

May 1, 1995·Journal of Chemical Neuroanatomy·A MansourS J Watson
Dec 15, 1994·The Journal of Comparative Neurology·A MansourS J Watson
Jun 1, 2000·Naunyn-Schmiedeberg's Archives of Pharmacology·L GaziD Feuerbach
Jul 20, 2005·Mini Reviews in Medicinal Chemistry·J W Huffman
Feb 14, 2006·Brain Research·Jian-Ping GongGeorge R Uhl
Mar 24, 2006·The European Journal of Neuroscience·M BeltramoA Reggiani
Apr 7, 2006·Handbook of Experimental Pharmacology·K Mackie
Oct 16, 2007·British Journal of Pharmacology·C BenitoJ Romero
May 9, 2008·Journal of Neuroendocrinology·K Mackie
May 22, 2010·Journal of Psychopharmacology·José L LanciegoRafael Franco
Jul 2, 2010·British Journal of Pharmacology·Brady K Atwood, Ken Mackie
Jul 24, 2010·British Journal of Pharmacology·M S García-GutiérrezJ Manzanares
Sep 15, 2010·Journal of Psychopharmacology·María S García-Gutiérrez, Jorge Manzanares
Feb 8, 2011·Progress in Lipid Research·P Pacher, R Mechoulam
Feb 22, 2011·Neuroscience·R MaldonadoP Robledo
Mar 23, 2011·British Journal of Pharmacology·Esther ShohamiRaphael Mechoulam
Mar 25, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Antonio Ortega-AlvaroJorge Manzanares
Jun 16, 2011·British Journal of Pharmacology·Francisco NavarreteJorge Manzanares
Jul 26, 2011·Nature Neuroscience·Zheng-Xiong XiEliot L Gardner
Aug 16, 2011·British Journal of Pharmacology·María S García-GutiérrezJorge Manzanares
Dec 15, 2011·The Journal of Molecular Diagnostics : JMD·Fay WangYuling Luo
Mar 15, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Auxiliadora Aracil-FernándezJorge Manzanares
Jul 19, 2012·Annual Review of Psychology·Raphael Mechoulam, Linda A Parker
Apr 16, 2013·Journal of Neuroscience Methods·Jean-Ha BaekJohn C Ashton
Jul 3, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Francisco NavarreteJorge Manzanares
Jul 17, 2013·Addiction Biology·Antonio Ortega-ÁlvaroJorge Manzanares
Nov 5, 2014·Proceedings of the National Academy of Sciences of the United States of America·Hai-Ying ZhangZheng-Xiong Xi

❮ Previous
Next ❯

Citations

Nov 8, 2017·Journal of Labelled Compounds & Radiopharmaceuticals·Francesco SpinelliSimon M Ametamey
May 18, 2018·Clinical and Experimental Pharmacology & Physiology·Gianluca LavancoCarla Cannizzaro
Mar 14, 2019·The American Journal of Drug and Alcohol Abuse·Yosef Sarne
May 31, 2016·F1000Research·Arnau Busquets GarciaGiovanni Marsicano
Feb 16, 2019·British Journal of Pharmacology·Krista J SpillerZheng-Xiong Xi
Jul 3, 2019·British Journal of Pharmacology·Balapal S BasavarajappaShivakumar Subbanna
Oct 15, 2019·Synapse·Gabriel López-RamírezBenjamín Florán
Aug 28, 2019·British Journal of Pharmacology·Zheng-Xiong XiEliot L Gardner
Jan 10, 2019·Frontiers in Psychology·Angélica Torres-BerrioMauricio O Nava-Mesa
Jan 19, 2019·Brain Sciences·Balapal S Basavarajappa, Shivakumar Subbanna
Dec 14, 2018·Frontiers in Psychiatry·Laurie-Anne RoeckelKatia Befort
Jan 20, 2017·Frontiers in Cellular Neuroscience·Debra A Kendall, Guillermo A Yudowski
Jul 7, 2017·Frontiers in Pharmacology·Rafael N RuggieroLezio S Bueno-Junior
Aug 14, 2018·British Journal of Pharmacology·Pedro H GobiraFabricio A Moreira
Oct 18, 2020·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ewa GalajZheng-Xiong Xi
Dec 23, 2020·Journal of Neuroscience Research·Aida Mohammadkhani, Stephanie L Borgland
Dec 19, 2020·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Xia LiZheng-Xiong Xi
Apr 1, 2018·Progress in Neuro-psychopharmacology & Biological Psychiatry·Konstantin A DeminAllan V Kalueff
Dec 30, 2020·International Journal of Molecular Sciences·Qing-Rong LiuEmmanuel S Onaivi
Dec 31, 2020·International Journal of Molecular Sciences·Joanna Agnieszka Komorowska-Müller, Anne-Caroline Schmöle
Dec 31, 2020·International Journal of Molecular Sciences·Ewa Galaj, Zheng-Xiong Xi
Jan 23, 2021·International Journal of Molecular Sciences·Antonietta SantoroRosaria Meccariello
Dec 18, 2020·Frontiers in Psychiatry·Isadora L CortezFelipe V Gomes
Aug 20, 2018·Neuropharmacology·Joanna Borowska-FieldingAlex Straiker
Mar 31, 2021·Drug and Alcohol Review·L Cinnamon BidwellHollis C Karoly
Apr 16, 2021·Journal of Neuroendocrinology·Nada A Sallam, Stephanie L Borgland
Apr 30, 2021·Cannabis and Cannabinoid Research·Patrick GrenierMary C Olmstead
May 8, 2021·Frontiers in Molecular Neuroscience·Luis Colón-CruzMartine Behra
Jun 12, 2021·Neuropharmacology·Gavin N PetrieMatthew N Hill
Aug 24, 2021·Expert Opinion on Therapeutic Targets·David CabañeroRafael Maldonado

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.